Stenocare A/S (CPH:STENO)
Denmark
· Delayed Price · Currency is DKK 0.3740
+0.0060 (1.63%)
Apr 1, 2025, 3:24 PM CET
Stenocare Company Description
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.
It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S
| Country | Denmark |
| Founded | 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Thomas Schnegelsberg |
Contact Details
Address: Nyholmsvej 4 Randers, Capital Region of Denmark 8930 Denmark | |
| Phone | 45 31 77 00 60 |
| Website | stenocare.dk |
Stock Details
| Ticker Symbol | STENO |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0061078425 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Skovlund Schnegelsberg | Chief Executive Officer, Co-Founder and Member of Executive Board |
| Rolf Steno Petersen | Co-Founder, Chief Commercial Officer and Director |
| Soren Kjaer | Co-Founder and Chief Operating Officer |
| Peter Bugge Johansen | Chief Financial Officer |